0001493152-20-016097.txt : 20200817
0001493152-20-016097.hdr.sgml : 20200817
20200817163030
ACCESSION NUMBER: 0001493152-20-016097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200813
FILED AS OF DATE: 20200817
DATE AS OF CHANGE: 20200817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GLECKEL LOUIS MD
CENTRAL INDEX KEY: 0001164762
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 201110570
MAIL ADDRESS:
STREET 1: C/O PROHEALTH CARE ASSOCIATES LLP
STREET 2: 2800 METRUS AVE
CITY: LAKE SUCCESS
STATE: NY
ZIP: 11042
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 621 N. SHADY RETREAT ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18901
BUSINESS PHONE: 2153450919
MAIL ADDRESS:
STREET 1: 621 N. SHADY RETREAT ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18901
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0306
4
2020-08-13
0
0000868278
ProPhase Labs, Inc.
PRPH
0001164762
GLECKEL LOUIS MD
621 N. SHADY RETREAT ROAD
DOYLESTOWN,
PA
18901
1
0
0
0
Common Stock, par value $0.0005
2020-08-13
4
P
0
50000
2.75
A
273840
D
These shares were purchased in a private transaction from Ted Karkus, Chairman and Chief Executive Officer of the Issuer, pursuant to the terms of a Stock Purchase Agreement
/s/ Louis Gleckel
2020-08-17